Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$0.18 - $0.48 $8,982 - $23,953
-49,904 Reduced 2.82%
1,720,199 $516,000
Q1 2023

May 15, 2023

SELL
$0.34 - $1.19 $65,200 - $228,202
-191,767 Reduced 9.77%
1,770,103 $761,000
Q4 2022

Feb 14, 2023

SELL
$1.03 - $2.0 $265,670 - $515,866
-257,933 Reduced 11.62%
1,961,870 $2.32 Million
Q3 2022

Nov 14, 2022

SELL
$0.42 - $3.92 $371,782 - $3.47 Million
-885,197 Reduced 28.51%
2,219,803 $5.15 Million
Q1 2022

May 16, 2022

BUY
N/A
3,105,000 New
3,105,000 $28.4 Million

Others Institutions Holding GRNA

# of Institutions
1
Shares Held
51.5K
Call Options Held
0
Put Options Held
0

About GreenLight Biosciences Holdings, PBC


  • Ticker GRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 151,460,000
  • Description
  • GreenLight Biosciences Holdings, a biotechnology company, manufactures and sells ribonucleic acid (RNA) products for human health and agriculture applications. Its products for human health include mRNA vaccines and therapeutics; and agricultural RNA products to protect honeybees and crops. The company was founded in 2008 and is headquartered in...
More about GRNA
Track This Portfolio

Track Hudson Bay Capital Management LP Portfolio

Follow Hudson Bay Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Hudson Bay Capital Management LP with notifications on news.